236 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

6955

Shandong Boan Biotechnology
HK$10.009.1%-38.3%HK$5.4bHK$11.27PE78.3xS29.0%n/a

2509

Qyuns Therapeutics
HK$23.20-25.0%n/aHK$5.2bn/aPS78xn/an/a

2487

Cutia Therapeutics
HK$16.6413.7%-16.8%HK$5.1bHK$15.02PS23xE47.2%n/a

2487

Cutia Therapeutics
HK$16.6413.7%-16.8%HK$5.1bHK$15.02PS23xE47.2%n/a

2487

Cutia Therapeutics
HK$16.6413.7%-16.8%HK$5.1bHK$15.02PS23xE47.2%n/a

2480

Beijing Luzhu Biotechnology
HK$24.0010.3%-32.3%HK$4.8bHK$30.65PB4.6xE47.5%n/a

9966

Alphamab Oncology
HK$4.7282.2%-45.1%HK$4.5bHK$4.36PS16.1xE70.1%n/a

9966

Alphamab Oncology
HK$4.7282.2%-45.1%HK$4.5bHK$4.36PS16.1xE70.1%n/a

9966

Alphamab Oncology
HK$4.7282.2%-45.1%HK$4.5bHK$4.36PS16.1xE70.1%n/a

775

CK Life Sciences Int'l. (Holdings)
HK$0.46-16.4%-44.6%HK$4.4bn/aPE39.8xn/a1.9%

775

CK Life Sciences Int'l. (Holdings)
HK$0.46-16.4%-44.6%HK$4.4bn/aPE39.8xn/a1.9%

1477

Ocumension Therapeutics
HK$6.3032.4%-17.6%HK$4.3bHK$9.89PS12.5xE73.7%n/a

1477

Ocumension Therapeutics
HK$6.3032.4%-17.6%HK$4.3bHK$9.89PS12.5xE73.7%n/a

1477

Ocumension Therapeutics
HK$6.3032.4%-17.6%HK$4.3bHK$9.89PS12.5xE73.7%n/a

775

CK Life Sciences Int'l. (Holdings)
HK$0.4110.7%-40.7%HK$4.0bn/aPB1xn/a0%

2179

Jiangsu Recbio Technology
HK$8.09-9.0%-32.5%HK$3.9bHK$13.00PS80.6xE38.2%n/a

1541

ImmuneOnco Biopharmaceuticals (Shanghai)
HK$8.1966.1%n/aHK$3.1bHK$16.39PS379.5xS-81.8%n/a

1541

ImmuneOnco Biopharmaceuticals (Shanghai)
HK$8.1966.1%-73.5%HK$3.1bHK$16.39PS379.5xS-81.8%n/a

1541

ImmuneOnco Biopharmaceuticals (Shanghai)
HK$8.1966.1%n/aHK$3.1bHK$16.39PS379.5xS-81.8%n/a

2315

Biocytogen Pharmaceuticals (Beijing)
HK$7.5019.8%-51.9%HK$3.0bHK$15.00PS3.4xE109.2%n/a

2171

CARsgen Therapeutics Holdings
HK$4.7961.3%-42.6%HK$2.7bHK$6.90PS389.8xE23.4%n/a

2171

CARsgen Therapeutics Holdings
HK$4.7961.3%-42.6%HK$2.7bHK$6.90PS389.8xE23.4%n/a

2171

CARsgen Therapeutics Holdings
HK$4.7961.3%-42.6%HK$2.7bHK$6.90PS389.8xE23.4%n/a

1873

Viva Biotech Holdings
HK$1.36-12.3%n/aHK$2.6bHK$7.69PS1xE77.9%n/a
Page 7 of 10
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.